{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06378151",
            "orgStudyIdInfo": {
                "id": "2023P002243"
            },
            "organization": {
                "fullName": "Brigham and Women's Hospital",
                "class": "OTHER"
            },
            "briefTitle": "Time-limited Trials in the Emergency Department",
            "officialTitle": "Time-limited Trials in the Emergency Department: A Randomized Trial",
            "therapeuticArea": [
                "Other"
            ],
            "study": "time-limited-trials-in-the-emergency-department"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-04",
            "overallStatus": "NOT_YET_RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-05-01",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-02-28",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-09-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-02-08",
            "studyFirstSubmitQcDate": "2024-04-17",
            "studyFirstPostDateStruct": {
                "date": "2024-04-22",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-04-17",
            "lastUpdatePostDateStruct": {
                "date": "2024-04-22",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Kei Ouchi",
                "investigatorTitle": "Associate Professor of Emergency Medicine",
                "investigatorAffiliation": "Brigham and Women's Hospital"
            },
            "leadSponsor": {
                "name": "Brigham and Women's Hospital",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "A randomized controlled trial of a structured conversation between clinicians and patients/surrogates to facilitate shared decision-making for intensive care use in seriously ill older adults being admitted to the intensive care unit from the emergency department.",
            "detailedDescription": "A randomized controlled trial of a structured conversation between clinicians and patients/surrogates to facilitate shared decision-making for intensive care use (i.e., Time-Limited Trial, TLT) in seriously ill older adults being admitted to the intensive care unit from the emergency department (ED).\n\nThe goal is to evaluate the feasibility and acceptability of TLT initiated in the ED for seriously ill older adults who are starting intensive care.\n\nThe main questions it aims to answer are:\n\n* Is TLT feasible to be conducted by trained ED clinicians?\n* Do patients or their surrogates find TLT acceptable in understanding and respecting their end-of-life care preferences?\n\nParticipants will be:\n\n* Attending physicians, resident physicians, or mid-level providers working in the ED who are willing to be randomized to become the study interventionists to conduct TLT conversations.\n* Seriously ill older adults receiving intensive care in the ED.\n\nResearchers will compare clinicians using TLT with those providing usual care to see if TLT leads to improved patient-centered decision-making and better alignment with patients' end-of-life care preferences."
        },
        "conditionsModule": {
            "conditions": [
                "Emergencies"
            ],
            "keywords": [
                "Time-Limited Trials; emergency department; palliative care"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "interventionModelDescription": "Clinician-level randomization",
                "primaryPurpose": "HEALTH_SERVICES_RESEARCH",
                "maskingInfo": {
                    "masking": "SINGLE",
                    "whoMasked": [
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 40,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Intervention group",
                    "type": "EXPERIMENTAL",
                    "description": "Attending physicians, resident physicians, or mid-level providers working in the ED who are willing to be randomized to become the study interventionists.",
                    "interventionNames": [
                        "Other: TLT training"
                    ]
                },
                {
                    "label": "Control group",
                    "type": "NO_INTERVENTION",
                    "description": "Attending physicians, resident physicians, or mid-level providers working in the ED who are willing to be randomized to become the study interventionists."
                }
            ],
            "interventions": [
                {
                    "type": "OTHER",
                    "name": "TLT training",
                    "description": "Emergency clinicians assigned to the intervention group will receive the following training and resources.\n\n1. The TLT Conversation Guide: The structured conversation guide entails discussing patients' values and goals, prognosis, and shared decision-making to use a trial of intensive care. Originally used in ICU settings, we systematically refined the guide to be used in the ED incorporating inputs from patient advisors' and emergency clinicians' inputs.\n2. Clinician Training: The clinician training will include a one-hour didactic on research methodologies and serious illness communication skills, followed by a four-hour communication training with trained actors.\n3. EHR Documentation: An EHR template for documenting the TLT conversation findings has been developed.\n4. Intensivist Communication: A standard template to communicate the TLT conversation findings to the intensivists has been developed.",
                    "armGroupLabels": [
                        "Intervention group"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Time to complete TLT conversations",
                    "description": "With direct observation, the study team will record how long (e.g., minutes) it takes to complete the TLT conversations by the interventionist ED clinicians.",
                    "timeFrame": "Immediately after the intervention (TLT conversation)"
                },
                {
                    "measure": "Patient-reported acceptability of TLT conversations",
                    "description": "A 5-point Likert scale (i.e., \"How acceptable was it for your doctor to talk to you about your expectations for ICU care?\" and \"How likely would you recommend this conversation for other patients like you?\" \"Not at all (1)\" to \"Completely (5)\").",
                    "timeFrame": "Immediately after the intervention (TLT conversation)"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Intervention fidelity",
                    "description": "With direct observation, the study team will record the completion of TLT components using an intervention fidelity checklist.",
                    "timeFrame": "Immediately after the intervention (TLT conversation)"
                },
                {
                    "measure": "Clinician-reported feasibility",
                    "description": "The study team will ask the interventionist emergency clinician to complete two 5-point Likert scale questions.",
                    "timeFrame": "Immediately after the intervention (TLT conversation)"
                },
                {
                    "measure": "Clinician-reported satisfaction",
                    "description": "The study team will ask the interventionist emergency clinician to complete 5-point Likert scale questions (i.e., \"How satisfied are you with the conversation? \"Not at all (1)\" to \"Completely (5)\").",
                    "timeFrame": "Immediately after the intervention (TLT conversation)"
                },
                {
                    "measure": "EHR documentation by inpatient clinicians",
                    "description": "Review EHR for new documentation of reference to TLT, serious illness conversation, change in code status, or advance directive forms by inpatient clinicians.",
                    "timeFrame": "After 24 hours, 48 hours, and 1 week"
                },
                {
                    "measure": "Heard and understood",
                    "description": "A National Quality Forum endorsed, validated measure for palliative care modified to fit the context of serious illness conversations.",
                    "timeFrame": "Immediately after the intervention (TLT conversation)"
                },
                {
                    "measure": "Patient-reported end-of-life quality of communication",
                    "description": "A validated, quality of end-of-life communication survey.",
                    "timeFrame": "Immediately after the intervention (TLT conversation)"
                },
                {
                    "measure": "Decisional regret scale",
                    "description": "A validated survey of decisional regret.",
                    "timeFrame": "After 24 hours, 48 hours, and 1 week"
                },
                {
                    "measure": "The number of days to the first family meeting in ICU",
                    "description": "The number of days from ICU admission to the first family meeting was documented by the ICU clinical team.",
                    "timeFrame": "Immediately after patient's discharge or death"
                },
                {
                    "measure": "ICU length of stay (LOS)",
                    "description": "The ICU LOS is recorded in days, from admission to the ICU until discharge, based on hospital records.",
                    "timeFrame": "Immediately after patient's discharge or death"
                },
                {
                    "measure": "Hospital LOS",
                    "description": "Hospital LOS is recorded in days, from admission to the hospital until discharge, as recorded in the patient's hospital record.",
                    "timeFrame": "Immediately after patient's discharge or death"
                },
                {
                    "measure": "The number of family meetings",
                    "description": "The total number of family meetings conducted in the ICU, as documented in patient records.",
                    "timeFrame": "Immediately after patient's discharge or death"
                },
                {
                    "measure": "ICU procedures (e.g., CPR, pressors, etc.)",
                    "description": "The number and type of specific ICU procedures performed, such as CPR or the use of pressors, will be recorded for each patient.",
                    "timeFrame": "Immediately after patient's discharge or death"
                },
                {
                    "measure": "ICU mortality",
                    "description": "ICU mortality is the percentage of patients who die while in the ICU, documented by the hospital's patient management system.",
                    "timeFrame": "Immediately after patient's discharge or death"
                },
                {
                    "measure": "Patterns of hospital disposition",
                    "description": "Hospital disposition refers to the patient's status upon discharge, including return home, transfer to another facility, or death, as noted in discharge records.",
                    "timeFrame": "Immediately after patient's discharge or death"
                },
                {
                    "measure": "Rate of hospice utilization",
                    "description": "Hospice utilization is recorded as the incidence of patients transferred to hospice care from the hospital, verified by hospice admission records.",
                    "timeFrame": "Immediately after patient's discharge or death"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Physician's eligibility:\n\nInclusion Criteria:\n\n* Attending physicians, resident physicians, or mid-level providers working in the ED who are willing to be randomized to become the study interventionists.\n\nExclusion Criteria:\n\n* Emergency clinicians unwilling to consent and be randomized to intervention TLT training.\n\nPatient's eligibility:\n\nThe subjects will be seriously ill older adults, or their surrogates being cared for by the participating emergency clinicians (both the intervention or control arms). If the emergency clinicians determine that the patient is not able to provide consent due to cognitive impairment, dementia, delirium, or critical illness, the surrogates will participate in the TLT conversations.\n\nInclusion Criteria:\n\n1. \u226550 years or older with \u2265one serious life-limiting illness\\* being admitted to the intensive care unit in the ED; or\n2. \u226575 years or older being admitted to intensive care unit in the ED; or\n3. ED clinicians will not be surprised if the patient died in the current hospital admission; and\n4. English speaking \\*Serious illness criteria with high one-year mortality are selected based on best practice recommendations such as 1) stage III/IV or metastatic cancer; 2) end-stage renal disease on dialysis; 3) chronic heart/lung disease requiring home oxygen supplementation or experiencing shortness of breath with walking; 4) moderate to severe dementia (surrogate required for enrollment); or 5) \u22652 hospitalizations in the past six months.\n\nExclusion Criteria:\n\n1. Unable or unwilling to provide informed consent; or\n2. Non-English speaking; or\n3. Clinically inappropriate, determined by emergency clinicians, and no surrogate is available",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Kei Ouchi, MD, MPH",
                    "role": "CONTACT",
                    "phone": "617-732-5640",
                    "email": "kouchi@bwh.harvard.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Kei Ouchi, MD, MPH",
                    "affiliation": "Brigham and Women's Hospital",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Brigham and Women's Hospital",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02115",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                }
            ]
        },
        "referencesModule": {
            "references": [
                {
                    "pmid": "26596879",
                    "type": "BACKGROUND",
                    "citation": "Gramling R, Stanek S, Ladwig S, Gajary-Coots E, Cimino J, Anderson W, Norton SA; AAHPM Research Committee Writing Group; Aslakson RA, Ast K, Elk R, Garner KK, Gramling R, Grudzen C, Kamal AH, Lamba S, LeBlanc TW, Rhodes RL, Roeland E, Schulman-Green D, Unroe KT. Feeling Heard and Understood: A Patient-Reported Quality Measure for the Inpatient Palliative Care Setting. J Pain Symptom Manage. 2016 Feb;51(2):150-4. doi: 10.1016/j.jpainsymman.2015.10.018. Epub 2015 Nov 17."
                },
                {
                    "pmid": "17040146",
                    "type": "BACKGROUND",
                    "citation": "Engelberg R, Downey L, Curtis JR. Psychometric characteristics of a quality of communication questionnaire assessing communication about end-of-life care. J Palliat Med. 2006 Oct;9(5):1086-98. doi: 10.1089/jpm.2006.9.1086."
                },
                {
                    "pmid": "12926578",
                    "type": "BACKGROUND",
                    "citation": "Brehaut JC, O'Connor AM, Wood TJ, Hack TF, Siminoff L, Gordon E, Feldman-Stewart D. Validation of a decision regret scale. Med Decis Making. 2003 Jul-Aug;23(4):281-92. doi: 10.1177/0272989X03256005."
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000004630",
                    "term": "Emergencies"
                }
            ],
            "ancestors": [
                {
                    "id": "D000020969",
                    "term": "Disease Attributes"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M7796",
                    "name": "Emergencies",
                    "asFound": "Emergency",
                    "relevance": "HIGH"
                },
                {
                    "id": "M22700",
                    "name": "Disease Attributes",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        }
    },
    "hasResults": false
}